Registered Plan Private Investments (Registered Plan Private Investments) COGS-to-Revenue : 0.00 (As of Dec. 2019)

View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments COGS-to-Revenue?

Registered Plan Private Investments's Cost of Goods Sold for the three months ended in Dec. 2019 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2019 was $0.00 Mil.

Registered Plan Private Investments's COGS to Revenue for the three months ended in Dec. 2019 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Registered Plan Private Investments's Gross Margin % for the three months ended in Dec. 2019 was N/A%.

Registered Plan Private Investments COGS-to-Revenue Historical Data

The historical data trend for Registered Plan Private Investments's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Registered Plan Private Investments COGS-to-Revenue Chart

Registered Plan Private Investments Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

COGS-to-Revenue

Registered Plan Private Investments Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
COGS-to-Revenue	Get a 7-Day Free Trial											-	-	-	-	-

Registered Plan Private Investments COGS-to-Revenue Calculation

Registered Plan Private Investments's COGS to Revenue for the fiscal year that ended in Dec. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Registered Plan Private Investments's COGS to Revenue for the quarter that ended in Dec. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Registered Plan Private Investments (OTCPK:LXGTF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Registered Plan Private Investments's Gross Margin % for the three months ended in Dec. 2019 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Registered Plan Private Investments COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Registered Plan Private Investments's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9

Website

https://lexingtonbiosciences.com

Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired • 10-24-2018

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired • 02-15-2019

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired • 05-01-2018

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired • 07-25-2018

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired • 07-03-2018

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired • 08-21-2018

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired • 04-02-2019

Lexington Engages with Major Canadian University and Provides Clinical Trial Update

By Marketwired Marketwired • 05-08-2018